INNOVATE Corp. (VATE)
Automate Your Wheel Strategy on VATE
With Tiblio's Option Bot, you can configure your own wheel strategy including VATE - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol VATE
- Rev/Share 75.6841
- Book/Share -15.7605
- PB -0.2632
- Debt/Equity -3.069
- CurrentRatio 0.457
- ROIC 0.0281
- MktCap 60012671.0
- FreeCF/Share 0.1597
- PFCF 28.5775
- PE -0.7795
- Debt/Assets 0.7744
- DivYield 0
- ROE 0.4014
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
INNOVATE Launches Indebtedness Refinancing Transactions
Published: July 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
$48.7 million privately negotiated convertible notes exchanges.$330 million exchange offer of senior secured notes and solicitation of consentsAgreement in principle to extend revolving credit agreementAgreement in principle to amend and extend the CGIC noteAgreement in principle to extend Spectrum notesAgreement in principle to amend and extend the R2 Technologies note
Read More
INNOVATE Corp. (VATE) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
INNOVATE Corp. (NYSE:VATE ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Anthony Rozmus - Investor Relations Paul Voigt - Interim Chief Executive Officer Mike Sena - Chief Financial Officer Conference Call Participants Operator Good afternoon. And welcome to INNOVATE's First Quarter 2025 Earnings Conference Call.
Read More
INNOVATE Corp. to Report Fourth Quarter and Full Year 2024 Results on March 31st
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2024 on Monday, March 31, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.
Read More
MediBeacon® Transdermal GFR System receives device approval in China
Published: February 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The Clinical Kidney Journal in February published MediBeacon study results on measured GFR (mGFR) using relmapirazin versus estimated GFR (eGFR) for the purpose of classifying patient Chronic Kidney Disease (CKD) stages.
Read More
About INNOVATE Corp. (VATE)
- IPO Date 2009-07-13
- Website https://www.innovatecorp.com
- Industry Engineering & Construction
- CEO Paul Kenneth Voigt
- Employees 3135